Showing results (1251-1260 of 1,764) with videos related to
Sort By:
Pageof 177
Cellular & Molecular Immunology|May 31, 2024
TRIM33 plays a critical role in regulating dendritic cell differentiation and homeostasis by modulating Irf8 and Bcl2l11 transcriptionXiangyi Shen, Xiaoguang Li, Tao Wu, et al.Cellular & Molecular Immunology|May 13, 2024
Eomesodermin spatiotemporally orchestrates the early and late stages of NK cell development by targeting KLF2 and T-bet, respectivelyJunming He, Donglin Chen, Wei Xiong, et al.Cellular & Molecular Immunology|May 14, 2024
Neutrophil-macrophage communication via extracellular vesicle transfer promotes itaconate accumulation and ameliorates cytokine storm syndromeHaixia Kang, Ting Liu, Yuanyuan Wang, et al.Cellular & Molecular Immunology|December 7, 2025
PA28γ-containing tumor-derived exosomes promote T-cell dysfunction in head and neck squamous cell carcinomaYing Wang, Shiyu Zhang, Yang Yang, et al.Cellular & Molecular Immunology|November 25, 2025
DIS3 licenses B cells for plasma cell differentiation in humansEmma Miglierina, Julien Bouder, Delfina Ordanoska, et al.Cellular & Molecular Immunology|February 5, 2025
Cell-associated galectin 9 interacts with cytotoxic T cells confers resistance to tumor killing in nasopharyngeal carcinoma through autophagy activationNgar-Woon Kam, Cho Yiu Lau, Jeffrey Yan Ho Lau, et al.Cellular & Molecular Immunology|February 5, 2025
Peroxisome proliferator-activated receptor alpha is an essential factor in enhanced macrophage immune function induced by angiotensin-converting enzymeSuguru Saito, Duo-Yao Cao, Ellen A Bernstein, et al.Cellular & Molecular Immunology|December 9, 2024
Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitorsElena Catanzaro, Manuel Beltrán-Visiedo, Lorenzo Galluzzi, et al.Cellular & Molecular Immunology|December 11, 2023
Oxidative stress-initiated one-carbon metabolism drives the generation of interleukin-10-producing B cells to resolve pneumoniaYing Fu, Baichao Yu, Qi Wang, et al.Cellular & Molecular Immunology|December 7, 2023
The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activationFan Luo, Han Li, Wenjuan Ma, et al.Pageof 177